布地奈德缓释胶囊全网公布的2025年的最新价格

Introduction: Budesonide sustained-release capsules are an effective drug for the treatment of Crohn's disease. Its price, quantity and efficacy have attracted much attention from patients. The following is the latest information on budesonide sustained-release capsules in 2025 published online, aiming to provide patients with practical reference.

The latest price of budesonide sustained-release capsules in 2025 published on the entire website

The price varies depending on factors such as region, drug brand and specification. In 2025, the latest prices announced on the entire Internet show that there are large differences in the prices of different versions of budesonide sustained-release capsules.

Overview of the overseas version price

Currently, budesonide sustained-release capsules are not yet on the market in China, and patients need to purchase the overseas version through regular channels. The specification of a box of the German version of budesonide sustained-release capsules is 3 mg x 100 capsules, and the price of a box is approximately US$287.

Germany Dr. Falk Pharma GmbH produces and exports the Turkish version of budesonide in a box of 3mg*100 pills, and the price of a box is about US$192. These prices are for reference only, and the actual purchase may vary due to factors such as region, pharmacy, purchase time, etc.

The quantity of budesonide sustained-release capsules to be prepared

The quantity to be prepared needs to be determined according to the patient’s specific condition and medication plan. Knowing the quantity of budesonide sustained-release capsules to prepare can help patients arrange their drug purchase plans reasonably and avoid drug discontinuation or drug waste.

Standard treatment course dosage

For patients with Crohn's disease, the standard treatment course of budesonide extended-release capsules is usually 8 weeks. Adult patients take 9 mg orally once daily for up to 8 weeks. For example, each box contains 100 capsules of 3 mg. A patient taking 9 mg every day will need about 90 capsules a month, that is, 1 box. Patients can plan the quantity of medicines in advance according to their own condition and medication plan.

Personalized medication preparation suggestions

Due to differences in patients’ conditions and medication regimens, the number of medications to be prepared also needs to vary from person to person. It is recommended that patients develop a personalized drug preparation plan according to their own conditions under the guidance of a doctor. At the same time, pay attention to the storage conditions and validity period of drugs to ensure the quality and safety of drugs.

The efficacy of budesonide sustained-release capsules

Budesonide sustained-release capsules can effectively relieve the symptoms of Crohn's disease and improve the quality of life of patients by inhibiting the occurrence of inflammation in the intestine and the response of the immune system. Its efficacy is remarkable and highly recognized by patients.

Significant anti-inflammatory effect

As a glucocorticoid drug, budesonide sustained-release capsules have anti-inflammatory effects. They can inhibit the activity of inflammatory cells and reduce the release of inflammatory mediators, thereby reducing the inflammatory response of the intestinal mucosa, helping to relieve symptoms such as abdominal pain, diarrhea, and bloody stools, and promoting the repair and regeneration of the intestinal mucosa.

Local action reduces side effects

Compared with traditional glucocorticoid drugs, budesonide sustained-release capsules have fewer systemic side effects and can release drugs through the intestines to achieve local effects and reduce the impact on other parts of the body. While enjoying the therapeutic effects, patients can reduce the risk of systemic side effects such as osteoporosis and diabetes.